RESEARCHER PROFILE (Filmed January 2024)
Laureate Professor Clare Collins AO
Nutrition and Dietetics in the School of Health Sciences,
University of Newcastle & Director, Food and Nutrition Research Program
Hunter Medical Research Institute
New South Wales, Australia
Laureate Professor Clare Collins is helping people access effective medical nutrition therapies that significantly reduce their risk of chronic disease. She and her team are developing innovative technologies, including apps and online programmes.
Prof Collins is Laureate Professor in Nutrition and Dietetics in the School of Health Sciences, College of Health, Medicine and Wellbeing. She has received three prestigious NHMRC Research Fellowships, is currently Director of Hunter Medical Research Institute, Food and Nutrition Program and been a dietitian for over 40 years.
Laureate Professor Collins has made major contributions to our knowledge on the impact of improving diet quality and food patterns on health and wellbeing outcomes. Her research in precision and personalised nutrition is driving a paradigm shift in technologies that improve delivery of medical nutrition therapy to under-served groups based on life-stage, socio-economic status or geographic location, for whom the chronic disease burden is 40-50% higher. This is generating new knowledge on cost-effective models of care that are available online or can be embedded in health settings.
Her passion was fuelled growing up as one of nine children and being in the first generation of her family to have the opportunity complete year 12 and go to university. She learnt from an early age the meaning of hard work, the importance of grasping opportunities when they arose and the importance of share the fruits of those opportunities.
Laureate Professor Collins is a Fellow of four prestigious bodies, the Australian Academy of Health and Medical Sciences, the Nutrition Society of Australia, Dietitians Australia, and the Royal Society of NSW. As the most successful research dietitian globally, her team includes dietitians, nutritionists, biochemists, computer scientists, biomedical engineers and software developers.
She has been awarded over $29 million dollars in research grants, published over 450 manuscripts and supervised 35 PhD and Master candidates to completion so far. Laureate Professor Collins is a great believer in sharing her knowledge through translation of nutrition science to benefit the public.
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
-
Iodine in pregnancy on baby brain and nervous system development
Dr Karen Best is Senior Research Fellow in the South Australian Health and Medical Research Institute (SAHMRI) Women and Kids Theme. She is a Registered Midwife with a unique breadth of experience in clinical project management, academic skills and knowledge translation and is committed to better understanding the essential role that modifiable exposures in pregnancy play in setting the foundations for a healthy start to life.
-
CASE STUDY Link between levels of extracellular vesicles in the blood and tissue damage caused by diseases
A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.
This study revealed, for the first time, a link between levels of EVs in the blood and tissue damage caused by diseases such as leukaemia.
Researchers hope to leverage the critical new insight to develop a blood test to monitor cancer patients with tissue damage, which could, in future, enhance treatment strategies for blood cancers and other diseases.
